Search Login Register

Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) Summary

Description: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.

Also Known As: Lipoprotein Lipase Deficiency, Familial; Apolipoprotein C II Deficiency; Familial Hyperchylomicronemia; Familial Lipoprotein Lipase Deficiency; Hyperchylomicronemia, Familial Show All >>

Networked: 66 relevant articles (0 outcomes, 6 trials/studies) for this Disease

Key Drugs and Agents for Hyperlipoproteinemia Type I

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Lipoprotein Lipase (Diacylglycerol Lipase) : 4 studies in 27 results : IBA
  2. Lipoproteins (Lipoprotein) : 4 studies in 17 results : IBA
  3. Lipase (Acid Lipase) : 2 studies in 6 results : FDA 1
  4. Apolipoprotein C-II (ApoC2) : 1 study in 10 results : IBA
  5. Triglycerides (Triacylglycerol) : 1 study in 1 result : IBA
  6. Factor XII (Hageman Factor) : 1 study in 1 result : IBA
  7. Apolipoproteins : 5 results : IBA
  8. Lipids : 3 results : IBA
  9. Insulin (Novolin) : 3 results : FDA 2
  10. Cholesterol : 3 results : IBA
Show All >>

Diseases Related to Hyperlipoproteinemia Type I

  1. Hypertriglyceridemia
  2. Pancreatitis
  3. Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
  4. Hyperlipoproteinemias
  5. Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
Show All >>

Key Therapies for Hyperlipoproteinemia Type I

Efficacy Chart >>
  1. Parenteral Nutrition : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.